HARVARD BIOSCIENCE INC HBIO
HARVARD BIOSCIENCE INC statistics & valuation
Market cap$27.2M
P / S0.3×
P / B2.0×
P / FCF5.0×
Net margin-65.5%
FCF margin6.3%
Net debt$27.3M
Enterprise value USD$54.5M
Earnings yield EBIT/EV-89.1%
Return on capital-83.6%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 57.7% | — | 58.2% | 58.9% | 53.7% | 56.9% | 56.8% | 55.4% | 52.3% | 50.6% |
| Operating margin | -56.1% | — | -6.6% | 1.7% | -6.1% | 1.7% | 0.2% | 0.3% | 0.8% | -0.8% |
| Net margin | -65.5% | — | -13.2% | -3.0% | -8.4% | -0.2% | -7.6% | -4.0% | -2.4% | -1.1% |
| FCF margin | 6.3% | — | -1.3% | 10.9% | -0.4% | 0.1% | 8.0% | 5.9% | 1.6% | 0.2% |
| Return on assets | -70.8% | -15.9% | -9.8% | -2.5% | -6.5% | -0.2% | -5.0% | -2.8% | -1.7% | -0.8% |
| Return on equity | -412.8% | -88.3% | -19.6% | -4.7% | -13.2% | -0.3% | -10.2% | -5.7% | -3.5% | -1.1% |
| Debt / equity | 2.61× | 2.41× | 0.58× | 0.51× | 0.65× | 0.58× | 0.63× | 0.66× | 0.73× | 0.15× |
| Current ratio | 2.20 | 0.81 | 0.82 | 1.85 | 2.20 | 2.43 | 2.46 | 2.12 | 2.27 | 3.39 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.